Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate and Genes under Its Transcriptional Regulation
Parkinson disease (PD) is a complex neurodegenerative disorder with largely unknown genetic mechanisms. While the degeneration of dopaminergic neurons in PD mainly takes place in the substantia nigra pars compacta (SN) region, other brain areas, including the prefrontal cortex, develop Lewy bodies, the neuropathological hallmark of PD. We generated and analyzed expression data from the prefrontal cortex Brodmann Area 9 (BA9) of 27 PD and 26 control samples using the 44K One-Color Agilent 60-mer Whole Human Genome Microarray. All samples were male, without significant Alzheimer disease pathology and with extensive pathological annotation available. 507 of the 39,122 analyzed expression probes were different between PD and control samples at false discovery rate (FDR) of 5%. One of the genes with significantly increased expression in PD was the forkhead box O1 (FOXO1) transcription factor. Notably, genes carrying the FoxO1 binding site were significantly enriched in the FDR–significant group of genes (177 genes covered by 189 probes), suggesting a role for FoxO1 upstream of the observed expression changes. Single-nucleotide polymorphisms (SNPs) selected from a recent meta-analysis of PD genome-wide association studies (GWAS) were successfully genotyped in 50 out of the 53 microarray brains, allowing a targeted expression–SNP (eSNP) analysis for 52 SNPs associated with PD affection at genome-wide significance and the 189 probes from FoxO1 regulated genes. A significant association was observed between a SNP in the cyclin G associated kinase (GAK) gene and a probe in the spermine oxidase (SMOX) gene. Further examination of the FOXO1 region in a meta-analysis of six available GWAS showed two SNPs significantly associated with age at onset of PD. These results implicate FOXO1 as a PD–relevant gene and warrant further functional analyses of its transcriptional regulatory mechanisms.
Vyšlo v časopise:
Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate and Genes under Its Transcriptional Regulation. PLoS Genet 8(6): e32767. doi:10.1371/journal.pgen.1002794
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002794
Souhrn
Parkinson disease (PD) is a complex neurodegenerative disorder with largely unknown genetic mechanisms. While the degeneration of dopaminergic neurons in PD mainly takes place in the substantia nigra pars compacta (SN) region, other brain areas, including the prefrontal cortex, develop Lewy bodies, the neuropathological hallmark of PD. We generated and analyzed expression data from the prefrontal cortex Brodmann Area 9 (BA9) of 27 PD and 26 control samples using the 44K One-Color Agilent 60-mer Whole Human Genome Microarray. All samples were male, without significant Alzheimer disease pathology and with extensive pathological annotation available. 507 of the 39,122 analyzed expression probes were different between PD and control samples at false discovery rate (FDR) of 5%. One of the genes with significantly increased expression in PD was the forkhead box O1 (FOXO1) transcription factor. Notably, genes carrying the FoxO1 binding site were significantly enriched in the FDR–significant group of genes (177 genes covered by 189 probes), suggesting a role for FoxO1 upstream of the observed expression changes. Single-nucleotide polymorphisms (SNPs) selected from a recent meta-analysis of PD genome-wide association studies (GWAS) were successfully genotyped in 50 out of the 53 microarray brains, allowing a targeted expression–SNP (eSNP) analysis for 52 SNPs associated with PD affection at genome-wide significance and the 189 probes from FoxO1 regulated genes. A significant association was observed between a SNP in the cyclin G associated kinase (GAK) gene and a probe in the spermine oxidase (SMOX) gene. Further examination of the FOXO1 region in a meta-analysis of six available GWAS showed two SNPs significantly associated with age at onset of PD. These results implicate FOXO1 as a PD–relevant gene and warrant further functional analyses of its transcriptional regulatory mechanisms.
Zdroje
1. LeesAJHardyJReveszT 2009 Parkinson's disease. Lancet 373 2055 2066
2. FerrerIMartinezABlancoRDalfoECarmonaM 2011 Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm 118 821 839
3. ZhengBLiaoZLocascioJJLesniakKARoderickSS 2010 PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2 52ra73
4. SutherlandGTMatigianNAChalkAMAndersonMJSilburnPA 2009 A cross-study transcriptional analysis of Parkinson's disease. PLoS ONE 4 e4955 doi:10.1371/journal.pone.0004955
5. EdwardsYJBeechamGWScottWKKhuriSBademciG 2011 Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS ONE 6 e16917 doi:10.1371/journal.pone.0016917
6. LanoueACDumitriuAMyersRHSoghomonianJJ 2010 Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease. Exp Neurol 226 207 217
7. BeachTGAdlerCHLueLSueLIBachalakuriJ 2009 Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta neuropathologica 117 613 634
8. PankratzNBeechamGWDestefanoALDawsonTMDohenyKF 2012 Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2. Annals of neurology 71 370 384
9. ElstnerMMorrisCMHeimKBenderAMehtaD 2011 Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta neuropathologica 122 75 86
10. SimunovicFYiMWangYMaceyLBrownLT 2009 Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 132 1795 1809
11. ZhangYJamesMMiddletonFADavisRL 2005 Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137B 5 16
12. MudoGMakelaJLibertoVDTselykhTVOlivieriM 2012 Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cellular and molecular life sciences : CMLS 69 1153 1165
13. NuberSPetrasch-ParwezEArias-CarrionOKochLKohlZ 2011 Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiology of disease 44 192 204
14. KurzADoubleKLLastres-BeckerITozziATantucciM 2010 A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS ONE 5 e11464 doi:10.1371/journal.pone.0011464
15. JiangHRenYYuenEYZhongPGhaediM 2012 Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nature communications 3 668
16. BraakHDel TrediciKRubUde VosRAJansen SteurEN 2003 Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 197 211
17. WakabayashiKTanjiKMoriFTakahashiH 2007 The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27 494 506
18. PankratzNWilkJBLatourelleJCDeStefanoALHalterC 2009 Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124 593 605
19. HamzaTHZabetianCPTenesaALaederachAMontimurroJ 2010 Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42 781 785
20. RhodesSLSinsheimerJSBordelonYBronsteinJMRitzB 2011 Replication of GWAS associations for GAK and MAPT in Parkinson's disease. Ann Hum Genet 75 195 200
21. Simon-SanchezJvan HiltenJJvan de WarrenburgBPostBBerendseHW 2011 Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet 19 655 661
22. DumitriuAPachecoCDWilkJBStrathearnKELatourelleJC 2010 Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Hum Mol Genet 20 1478 1487
23. International Parkinson Disease Genomics Consortium 2011 Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. The Lancet 377 641 649
24. CervelliMAmendolaRPolticelliFMariottiniP 2011 Spermine oxidase: ten years after. Amino Acids
25. KangSJScottWKLiYJHauserMAvan der WaltJM 2006 Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Mov Disord 21 2175 2180
26. TanEKKhajaviMThornbyJINagamitsuSJankovicJ 2000 Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 55 533 538
27. NakatomeMTunZShimadaSHondaK 1998 Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease. Biochem Biophys Res Commun 247 452 456
28. HotamisligilGSGirmenASFinkJSTivolEShalishC 1994 Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 9 305 310
29. HeinzenELGeDCroninKDMaiaJMShiannaKV 2008 Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 6 e1 doi:10.1371/journal.pbio.0060001
30. BarrettJCFryBMallerJDalyMJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263 265
31. MeiYZhangYYamamotoKXieWMakTW 2009 FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc Natl Acad Sci U S A 106 5153 5158
32. SuBLiuHWangXChenSGSiedlakSL 2009 Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Mol Neurodegener 4 32
33. KohHKimHKimMJParkJLeeHJ 2012 Silent Information Regulator 2 (Sir2) and Forkhead box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila Pten-induced kinase 1 (PINK1) Null Mutant. The Journal of biological chemistry
34. KuwaharaTTonegawaRItoGMitaniSIwatsuboT 2012 Phosphorylation of alpha-synuclein at Ser129 reduces neuronal dysfunction by lowering its membrane-binding property in Caenorhabditis elegans. The Journal of biological chemistry
35. KanaoTVenderovaKParkDSUntermanTLuB 2010 Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila. Hum Mol Genet 19 3747 3758
36. KanaoTSawadaTDaviesSAIchinoseHHasegawaK 2012 The Nitric Oxide-Cyclic GMP Pathway Regulates FoxO and Alters Dopaminergic Neuron Survival in Drosophila. PLoS ONE 7 e30958 doi:10.1371/journal.pone.0030958
37. ShimamuraMSatoNMorishitaR 2011 Experimental and clinical application of plasmid DNA in the field of central nervous diseases. Current gene therapy 11 491 500
38. SalehiZRajaeiF 2010 Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 17 1553 1556
39. TucciANallsMAHouldenHReveszTSingletonAB 2010 Genetic variability at the PARK16 locus. European journal of human genetics : EJHG 18 1356 1359
40. SatakeWNakabayashiYMizutaIHirotaYItoC 2009 Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature genetics 41 1303 1307
41. HoglingerGURizkPMurielMPDuyckaertsCOertelWH 2004 Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nature neuroscience 7 726 735
42. O'KeeffeGCTyersPAarslandDDalleyJWBarkerRA 2009 Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proceedings of the National Academy of Sciences of the United States of America 106 8754 8759
43. ChiYFanYHeLLiuWWenX 2011 Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease. Aging cell 10 368 382
44. TofarisGKKimHTHourezRJungJWKimKP 2011 Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proceedings of the National Academy of Sciences of the United States of America 108 17004 17009
45. BeachTGSueLIWalkerDGRoherAELueL 2008 The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007. Cell and tissue banking 9 229 245
46. KauffmannAGentlemanRHuberW 2009 arrayQualityMetrics–a bioconductor package for quality assessment of microarray data. Bioinformatics 25 415 416
47. HuangDWShermanBTLempickiRA 2008 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4 44 57
48. Huang daWShermanBTLempickiRA 2009 Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37 1 13
49. WillerCJLiYAbecasisGR 2010 METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26 2190 2191
50. BaronRMKennyDA 1986 The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 1173 1182
51. JastiSDudleyWNGoldwaterE 2008 SAS macros for testing statistical mediation in data with binary mediators or outcomes. Nurs Res 57 118 122
52. MacKinnonDPLockwoodCMHoffmanJMWestSGSheetsV 2002 A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7 83 104
53. GaoXStarmerJMartinER 2008 A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 32 361 369
54. SankohAJHuqueMFDubeySD 1997 Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16 2529 2542
55. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575
56. WebsterJAGibbsJRClarkeJRayMZhangW 2009 Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84 445 458
57. MaraganoreDMde AndradeMLesnickTGStrainKJFarrerMJ 2005 High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77 685 693
58. HarrisonPJHeathPREastwoodSLBurnetPWMcDonaldB 1995 The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200 151 154
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 6
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Rumors of Its Disassembly Have Been Greatly Exaggerated: The Secret Life of the Synaptonemal Complex at the Centromeres
- The NSL Complex Regulates Housekeeping Genes in
- Tipping the Balance in the Powerhouse of the Cell to “Protect” Colorectal Cancer
- Interplay between Synaptonemal Complex, Homologous Recombination, and Centromeres during Mammalian Meiosis